CRLCharles River Laboratories International, Inc.

CRL Stock Price, Valuation & Chart | Charles River Laboratories International, Inc.

Compare

$282.34-5.90 (-2.05%)

At close · 01 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Diagnostics & Research CRL intrinsic value CRL calculated fair value vs price

Overview Financials Dividends Ratios

CRL Historical price chart

CRL Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization13.60B

PE Ratio28.52

EPS9.9

Trading Volume686.83K

Today's High/Low289.9/280.91

Dividend Yield0.00

52 Week High/Low303.31/144.26

Shares Outstanding48.17M

CRL Financial Statement

CRL Analyst ratings

CRL Analysis & performance metrics

CRL Company profile

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services…

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions…

CRL Management team

Name

Position

Michael Gunnar KnellCFO

Interim Chief Financial Officer, Corporate Senior Vice President & Chief Accounting Officer

Matthew L. Daniel J.D.

Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Julie Frearson Ph.D.

Corporate Senior Vice President & Chief Scientific Officer

Victoria L. Creamer

Corporate Executive Vice President & Chief People Officer

Mark MintzCTO

Corporate EVice President, Chief Information Officer & Global Shared Services

Todd Spencer

Corporate Vice President of Investor Relations

Amy E. Cianciaruso

Corporate Senior Vice President, Chief Communications Officer & Government Relations

Joseph W. LaPlume J.D.

Corporate Executive Vice President of Corporate Development & Strategy

Name

Position

Michael Gunnar KnellCFO

Interim Chief Financial Officer, Corporate Senior Vice President & Chief Accounting Officer

Matthew L. Daniel J.D.

Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Julie Frearson Ph.D.

Corporate Senior Vice President & Chief Scientific Officer

Victoria L. Creamer

Corporate Executive Vice President & Chief People Officer

Mark MintzCTO

Corporate EVice President, Chief Information Officer & Global Shared Services

Todd Spencer

Corporate Vice President of Investor Relations

Amy E. Cianciaruso

Corporate Senior Vice President, Chief Communications Officer & Government Relations

Joseph W. LaPlume J.D.

Corporate Executive Vice President of Corporate Development & Strategy

Management Team

Michael Gunnar KnellCFO

Interim Chief Financial Officer, Corporate Senior Vice President & Chief Accounting Officer

Matthew L. Daniel J.D.

Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Julie Frearson Ph.D.

Corporate Senior Vice President & Chief Scientific Officer

Victoria L. Creamer

Corporate Executive Vice President & Chief People Officer

Mark MintzCTO

Corporate EVice President, Chief Information Officer & Global Shared Services

Todd Spencer

Corporate Vice President of Investor Relations

Amy E. Cianciaruso

Corporate Senior Vice President, Chief Communications Officer & Government Relations

Joseph W. LaPlume J.D.

Corporate Executive Vice President of Corporate Development & Strategy

Management

Michael Gunnar KnellCFO

Interim Chief Financial Officer, Corporate Senior Vice President & Chief Accounting Officer

Matthew L. Daniel J.D.

Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Julie Frearson Ph.D.

Corporate Senior Vice President & Chief Scientific Officer

Victoria L. Creamer

Corporate Executive Vice President & Chief People Officer

Mark MintzCTO

Corporate EVice President, Chief Information Officer & Global Shared Services

Todd Spencer

Corporate Vice President of Investor Relations

Amy E. Cianciaruso

Corporate Senior Vice President, Chief Communications Officer & Government Relations

Joseph W. LaPlume J.D.

Corporate Executive Vice President of Corporate Development & Strategy

Total 8 executives

CRL Frequently asked questions

What is Charles River Laboratories International, Inc. (CRL) Stock Price?

Current stock price of Charles River Laboratories International, Inc. (CRL) stock is $282.34. The stock price is -2.05% lower in the session. The intraday range can be seen from this page. Volume of Charles River Laboratories International, Inc. (CRL) stock is 686.83K.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Charles River Laboratories International, Inc. (CRL) stock price going up or down today?

The stock price of Charles River Laboratories International, Inc. (CRL) can change with earnings, company news, and overall market sentiment. Charles River Laboratories International, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Charles River Laboratories International, Inc. stock expensive at its current price?

Whether Charles River Laboratories International, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CRL on this page is 28.52. EPS on this page is 9.90. Compare those figures with peers and growth expectations before deciding if the current Charles River Laboratories International, Inc. price is justified.

How has the stock price of Charles River Laboratories International, Inc. (CRL) performed historically?

Historical performance for Charles River Laboratories International, Inc. (CRL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CRL reacted to past earnings and market events.

Should I buy Charles River Laboratories International, Inc. (CRL) stock, at this price?

Buying Charles River Laboratories International, Inc. (CRL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.